Cellular uptake of vitamin B12 in patients with chronic renal failure

Nephron - Clinical Practice

Volumn 99, Issue 2, 2005, Pages

  Obeid, Rima ^a   Kuhlmann, Martin ^a   Kirsch, Carl Martin ^a   Herrmann, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Holotranscobalamin; Homocysteine; Methylmalonic acid; Mononuclear cells

Indexed keywords

CYANOCOBALAMIN; CYSTATHIONINE; FOLIC ACID; HOLOTRANSCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; TRANSCOBALAMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL FUNCTION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMOCONCENTRATION; HEMODIALYSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR BINDING; VITAMIN METABOLISM;

ADULT; AGED; CELLS, CULTURED; CYSTATHIONINE; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; METHYLMALONIC ACID; MIDDLE AGED; VITAMIN B 12;

EID: 13244252581     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083132     Document Type: Article

References (29)

1. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 1998;11:239-245.
2. 12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003;41:1478-1488.
3. Van Guldener C, Robinson K: Homocysteine and renal disease. Semin Thromb Hemost 2000;26:313-324.
4. Bostom AG, Culleton BF: Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999;10:891-900.
5. Chauveau P, Chadefaux B, Coude M, et al: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;41(suppl):72-77.
6. Bachmann J, Tepel M, Raidt H, et al: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995;6:121-125.
7. Van Guldener C, Kulik W, Berger R, et al: Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 1999;56:1064-1071.
8. Guttormsen AB, Ueland PM, Svarstad E, Refsum H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997;52:495-502.
9. Dierkes J, Domrose U, Ambrosch A, et al: Response of hyperhomocysteinemia to folic acid supplementation in patients with endstage renal disease. Clin Nephrol 1999;51:108-115.
10. 12 and folate. Res Exp Med (Berl) 2001;200:155-168.
11. Thambyrajah J, Landray MJ, McGlynn FJ, et al: Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000;102:871-875.
12. Friedman AN, Bostom AG, Laliberty P, et al: The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: A randomized, controlled study. Am J Kidney Dis 2003;41:442-446.
13. Seetharam B, Li N: Transcobalamin II and its cell surface receptor. Vitam Horm 2000;59:337-366.
14. 12 homeostasis. Proc Natl Acad Sci USA 1996;93:8612-8617.
15. 12 homeostasis. Nephrol Dial Transplant 2003;18:1095-1100.
16. Friedman AN, Bostom AG, Selhub J, et al: The kidney and homocysteine metabolism. J Am Soc Nephrol 2001;12:2181-2189.
17. 12 by human lymphocytes and the relationships to the cell cycle. J Lab Clin Med 1984;103:70-81.
18. 12 by phytohaemagglutinin-transformed lymphocytes. Br J Haematol 1973;24:147-156.
19. Allen RH, Stabler SP, Savage DG, Lindenbaum J: Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42:978-988.
20. Stabler SP, Lindenbaum J, Savage DG, Allen RH: Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-3413.
21. Ulleland M, Eilertsen I, Quadros EV, et al: Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 2002:48:526-532.
22. Quadros EV, Matthews DM, Hoffbrand AV, Linnell JC: Synthesis of cobalamin coenzymes by human lymphocytes in vitro and the effect of folates and metabolic inhibitors. Blood 1976;48:609-619.
23. Koyama K, Usami T, Takeuchi O, et al: Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 2002;17:916-922.
24. Berliner N, Rosenberg LE: Uptake and metabolism of free cyanocobalamin by cultured human fibroblasts from controls and a patient with transcobalamin II deficiency. Metabolism 1981;30:230-236.
25. Barshop BA, Wolff J, Nyhan WL, et al: Transcobalamin II deficiency presenting with methylmalonic aciduria and homocystinuria and abnormal absorption of cobalamin. Am J Med Genet 1990;35:222-228.
26. Moelby L, Rasmussen K, Ring T, Nielsen G: Relationship between methylmalonic acid and cobalamin in uremia. Kidney Int 2000;57:265-273.
27. House AA, Wells GA, Donnelly JG, et al: Randomized trial of high-flux vs. low-flux haemodialysis: Effects on homocysteine and lipids. Nephrol Dial Transplant 2000;15:1029-1034.
28. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG: Impaired phagocytosis in dialysis patients: Studies on mechanisms. Am J Nephrol 1991;11:102-111.
29. Loehrer FM, Angst CP, Brunner FP, et al: Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: A cause for disturbed methylation reactions? Nephrol Dial Transplant 1998;13:656-661.